Curetis Reports Financial Results for the First Six Months of 2016
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis AG, "Curetis"), a developer of next-level molecular diagnostic so…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applicati…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation a…
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Kapa Biosystems announced today a partnership to provide an optimized NGS target…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the release of SeqCap EZ Exome Designs for target enrichment of the wheat,…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that The Centre for Genomic Research (CGR) at the University of Liver…
Roche today announced the global launch of the NimbleDesign tool, an online software that enables customers to easily de…
Roche today announced the global launch of its SeqCap EZ Pure Capture Bead Kit supporting target enrichment workflows pr…
Roche announced today the global launch and availability of a new comprehensive suite of SeqCap EZ Reagent kits for appl…